Skip to main content
Blizard Institute - Faculty of Medicine and Dentistry
  1. Blizard Institute
  2. All Staff
  3. Profiles

Professor Adina Michael-Titus, Lic Sci, M es Sci, Doct en Sci (Paris)

Adina

Professor of Neuroscience; Centre Lead for Neuroscience, Surgery and Trauma

Centre: Centre for Neuroscience, Surgery and Trauma

Email: a.t.michael-titus@qmul.ac.uk
Telephone: 020 7882 2290

Profile

Adina Michael-Titus was awarded a Doctorat en Sciences (France) in 1988, for studies on novel inhibitors of opioid peptide-degrading enzymes. She continued post-doctoral studies on opioid peptides, in Rouen and Paris until 1990, when she was offered the position of Lecturer in Physiology and Pharmacology in the School of Biological Sciences at Queen Mary. She became subsequently a Lecturer in Pharmacology at Barts and The London School of Medicine, and a Senior Lecturer in 2001. Between 2002 and 2004 she spent sabbatical research time as a Senior Scientist and Head of Section in Drug Discovery, with the pharmaceutical company Lundbeck A/S in Denmark. She became a Reader in 2007 and was awarded the title of Professor of Neuroscience in 2010. She is a Fellow of the British Pharmacological Society and is on the Board of Directors of the International Society for Studies on Fatty Acids and Lipids. She is also a Fellow of The Higher Education Academy. 

Professor Adina Michael-Titus is the Lead of the Neurotrauma Group in the Centre for Neuroscience, Surgery and Trauma. She teaches neuroscience, pharmacology and therapeutics, and has a particular research interest in the characterization and development of novel therapeutic approaches in several neurological diseases. She is Programme Director of the MSc in Neuroscience and Translational Medicine, whose main aim is to help train the next generation of scientists and physicians involved in rapid and successful clinical translation of fundamental discoveries in neuroscience. 

A large component of her present research programme is focused on neuroprotective agents in spinal cord injury and brain injury. Several of her present projects explore the remarkable therapeutic potential of natural compounds, such as the n-3 polyunsaturated fatty acids.  Her group has also started a programme of studies on new therapeutic directions in neurodegeneration following injury. She is an inventor on several patents, a member of several scientific and professional societies and regularly acts as a reviewer for the UK research councils. 

Back to top